Global Breast Cancer Diagnostic and Drug Technologies Market Anticipated to Surpass Valuation of $21.8 billion by 2022

Posted on 2018-06-21 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2018-Jun-21 — /EPR Network/ —In the present time, the number of women suffering from breast cancer is witnessing a surge. This has led towards necessity for efficient early diagnosis of breast cancer. Considering this fact, breast cancer research and development is attractive and requires attention from pharmaceutical firms. Drugs for breast cancer comprise a dynamic and growing global market, finds a latest study broadcasted to the wide database of Market Research Hub (MRH). The study is titled as “Breast Cancer Diagnostic and Drug Technologies: Global Markets” and provides detailed analysis of current and future market potential for breast cancer therapeutics worldwide. In addition, analysis of the competitive environment, pipeline drugs, blockbuster drugs and other diagnostic & therapeutic development has been elaborated.

Click here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1803596

This 154-pages precise study provides forecast and analysis of the global breast cancer diagnostic and drug technologies market. For market estimates, data has been provided for the year 2016, as the base year, 2017 and a forecast for 2022. In order to provide a clear vision of the industry, the report specifics currently available diagnostic breast cancer screening tests, breast cancer staging and prognostic technology advancements, predictive diagnostic tests and the latest therapy developments for breast cancer treatment.

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/breast-cancer-diagnostic-and-drug-technologies-global-markets-report.html

Key Highlights from the Study

As per the study key findings, the global breast cancer diagnostic and drug market should reach $21.8 billion by 2022 from $18.2 billion in 2017 at an impressive CAGR of 3.6% for the period 2017-2022. At present, the breast cancer diagnostic and drug technology markets include a variety of products approved for breast cancer treatment, including hormonal therapies, chemotherapeutic drugs, combinations and targeted therapies.
The research study further also analyses that there are many side effects, adverse reactions and safety concerns have come up which are associated with newer, innovative drugs. Therefore, drugs with improved safety and efficacy are needed to treat breast cancer effectively. The global breast cancer diagnostics market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. In fact, early breast cancer treatment and detection have improved the five-year survival rate for women diagnosed with cancer to nearly 80%.
The market overview section of the study reveals market dynamics which states that several targeted therapies have evolved over the last decades and several others are likely to reach the market in the next five year. Presently, common detection techniques for breast cancer are diagnostic mammography and ultrasound followed by biopsy. Studies clearly show that breast cancer treatment is far more effective when cancer is detected at an early stage.
Also, the report includes market estimates for breast cancer on the basis of diagnostic method into mammography, biopsy and companion diagnostics; and therapeutics by drug class such as HER2 inhibitors, mitotic inhibitors, anti-metabolites, aromatase inhibitors and hormone receptors, and geographic market segmentation.

In the final section of the report, a competitive landscape has been included to provide report audiences with a dashboard view. Comprehensive profiles of major players in the market, including Dako, Abbvie, Inc., Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company, Novartis International AG, and Pfizer, Inc.”

Enquire about this Report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1803596

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like In Vitro Diagnostics industry research reports and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick